WEBULL
WebtradeDownload

Zevia (ZVIA) Stock Sinks As Margin Pressure Deepens Loss Concerns

Simply Wall St · 1d ago

Zevia PBC stock just sank 13.5% to about US$1.48, even though the headline from this quarter was not a collapse in sales. The real story was a squeeze in profitability that kept the market on edge. Net sales for the quarter sat at US$45.0m, but earnings per share stayed in loss territory and investors reacted fast.

Step back from today’s price drop and a different picture starts to form. Zevia is still growing its trailing twelve month revenue and has been narrowing losses over several years. The key question now is whether that gradual margin repair can justify even this modest valuation over a multi year horizon.

Is Zevia PBC trading like a discounted turnaround, or is it already pricing in the margin repair story ahead of the earnings catch up? See how the current P/S and DCF picture line up in our valuation analysis for Zevia PBC.

Q2 2026 Earnings Summary

  • Revenue, Q2 2026 vs Q2 2025: US$45.0m vs. US$44.5m (up about 1%)
  • Net Loss, Q2 2026 vs Q2 2025: US$2.8m loss vs. US$0.7m loss (loss widened)
  • Basic EPS, Q2 2026 vs Q2 2025: loss of US$0.04 per share vs. loss of US$0.01 per share (loss per share increased)
  • Gross Margin, Q2 2026 vs Q2 2025: 48.9% vs. 48.7% (broadly stable with a slight improvement)

Prefer clear visuals instead of another wall of earnings tables and raw figures? View a complete picture of Zevia PBC's recent profitability and loss trend in our interactive company report for Zevia PBC.

NYSE:ZVIA Trailing 12-Month Earnings & Revenue History as at Aug 2026
NYSE:ZVIA Trailing 12-Month Earnings & Revenue History as at Aug 2026

Zevia bull case leans on revenue and brand momentum

Bulls argue Zevia can pair steady revenue growth with margin repair as brand reach and distribution improve. Q2 net sales of US$45.0m align with that slow build, especially with H1 revenue up 10.4% to US$91.1m and guidance that points to US$170m to US$175m for 2026. Gross margin at 48.9% and slightly positive adjusted EBITDA of about US$0.5m show the cost structure is capable of break even in a normal quarter. The Cardi B campaign, broad packaging refresh and focus on singles suggest management is attacking awareness and availability, which fits the “distribution and brand first” thesis. However, guidance for an adjusted EBITDA loss of US$2m to US$4m for the year and margin pressure in Q3 show the profitability fix is not yet on a straight line.

Bear case focuses on profitability setback and execution risk

Bears see Zevia as a low margin beverage stock that depends heavily on perfect execution and benign input costs. The widening net loss in Q2 to US$2.8m versus US$0.7m a year ago, despite relatively flat quarterly revenue, speaks directly to that concern. Management is flagging an US$11m cost headwind for 2026, expects Q3 gross margin nearer 46% and guides to a Q3 adjusted EBITDA loss of US$3.0m to US$3.5m. That undercuts the idea of a near term profit inflection. Marketing and G&A running higher as a share of sales, while the share price has fallen about 13% today and is down over 9% in a week, reinforce the risk that spending is running ahead of proven volume gains. The execution bar on singles rollout and in store activation remains high.

After Q2's wider loss and guidance for more margin pressure, it is fair to ask if Zevia PBC's issues are still mostly about marketing timing or if they hint at deeper structural problems in the cost base and route to profitability. Scan the independent risk analysis for Zevia PBC which shows 2 important warning signs

Take Control Of Your Next Move

If the mix of revenue growth, widening losses and margin questions around Zevia PBC has you watching for a better risk reward entry, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and see how new results shift the thesis. Once you are invested, use the Portfolio Command Center to cut through market noise and focus on the key updates that matter for your holdings.

For a longer term view, tap into the Community to see how other investors are thinking about Zevia PBC and similar stocks as new data comes through. By spotting potential catalysts and risks early, you can make more confident decisions and stay a step ahead of the market.

Seeking Alternatives Beyond Zevia PBC?

Some stocks are building quiet momentum while others are dropping out of focus. Use fresh data while it matters and move before the crowd catches up. Act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.